QSimulate provides quantum simulations to improve research and development in fields such as drug discovery and materials design.

QSimulate

QSimulate leverages quantum mechanics to provide simulations that aid in drug discovery, materials design, and quantum computing applications.

QSimulate | 1,827 followers on LinkedIn. Leveraging the power of quantum mechanics to solve industrial-scale problems like never before. | As QSimulate is expanding the team, we have multiple open positions including scientists, software engineers, project management, and business development.

Our offices are located in Boston MA, Berkeley CA, and Ghent, Belgium. For technical positions, we also consider remote options.

Vice President of Product at QSimulate

David Pearlman

Health & Bio Investor

Enke Bashllari, Ph.D.

Senior Scientist at QSimulate

Daniel Moberg

Software Engineer at QSimulate

Fredy Aquino

Trevor Barsamian , director of business development, shares how QUELO scales simulations and optimizes computing costs for drug discovery. Learn more about QUELO: https://lnkd.in/eFi88qQh

Why quantum for drug lead optimization? Our QUELO customer says: "...the ability to incorporate quantum mechanics into dynamics-based relative free energy methods bodes well for increasing the predictive accuracy of RBFE calculations against challenging targets." Learn more about QUELO, our quantum-enhanced lead optimization solution: https://lnkd.in/eFi88qQh

QSimulate CEO, Toru Shiozaki , is joining the panel at "Wine with AI Category Leaders" on October 15th, hosted by Hyperlink Ventures , OCV , and Mucker Capital during LA Tech Week. If you are in the LA area, we would love to see you there! Event link: https://lnkd.in/efn966qx

QSimulate will be at SC24 in Atlanta on Nov. 19-20! Stop by our demo pod within the AWS booth between 2-4 pm to learn more about what the optimal balance of simulation accuracy and compute efficiency can do for your discovery efforts.

Did you miss the live webinar for QUELO's state-of-the-art quantum-powered AI force field? You're in luck! Watch the recording of David Pearlman as he shares the latest update to QUELO, our quantum-enhanced lead optimization solution. Register here for the webinar on-demand: https://lnkd.in/euiuzp9A

Don't forget to register for this week's webinar introducing quantum-powered AI force fields! On Thursday, September 26, David Pearlman will discuss the latest innovation in our quantum-enhanced lead optimization solution, QUELO. Register now: https://lnkd.in/e3Bw9tWi

Attention Drug Discovery Leaders! Are you looking to achieve the perfect balance of accuracy and efficiency in lead optimization? Join us on Thursday, September 26 for an exclusive webinar introducing quantum-powered AI force fields—the latest innovation in our quantum-enhanced lead optimization solution, QUELO. Register now: https://lnkd.in/e3Bw9tWi

Are you a drug discovery leader curious about how quantum can positively impact your pipelines? Then David Pearlman ’s talk on September 18th at “QM in Pharma” is for you! David’s presentation highlights how the QM/MM approach (QUELO) leads to better results than traditional molecular mechanics methods in applications such as FEP and covalent ligand characterization. By developing a faster approach that can replace classical mechanics in molecular dynamics-based methods, QUELO has an immediate positive impact on drug discovery, especially in techniques like relative free energy calculations that require nanoseconds of sampling. Register here: https://lnkd.in/e4rvRgCM

Join David Pearlman in London on September 18th for his talk at "QM in Pharma" as he highlights QSimulate 's cutting-edge quantum technology. Register here: https://lnkd.in/e4rvRgCM Learn more about QSimulate's QM solutions: https://lnkd.in/ebTSsCrq

Metric
Company Name	QSimulate
Symbol
MSH ID	COM:QSIMULATE
Market	PRIVATE
Sector	Technology
Industry	Software & Technology
Country	US
Stage
Employee Count
Website	qsimulate.com
LinkedIn	qsimulate
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

QSIM

COM:QSIMULATE

QSimulate

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue